/stocks — the workspaceLOADING
All ELTPSEC filings, by type → · Earnings date & implied move · Search inside filings
ELITE PHARMACEUTICALS INC /NV/ (ELTP) is a pharmaceutical preparations company. Piotroski F-Score 7/8. Next earnings confirmed for 2026-08-13 (SEC filing). Fundamentals from SEC filings; prices are end-of-day.
What’s behind ELTP’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2026-03-31 vs 2025-03-31.
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from ELTP’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
A plain-English read on ELTP plus an auto-SWOT — built from ELTP's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate ELTP using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Has ELTP been issuing shares? Offering history →
↓ Download the fiscal-year statement table (XLSX) · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
No lawmaker has disclosed a trade in ELTP under the STOCK Act.
No tracked institution reported a position in ELTP in the latest 13F round.
Every figure is from ELTP’s SEC cash-flow statement. This describes how management deployed cash last period — it is not a grade of that deployment, not a forecast, and not investment advice. Whether reinvesting, paying down debt, or returning cash was the right call depends on the return each earns, which the filings do not settle. Educational information only.
No open-market Form 4 buys or sells reported for ELTP in the last ~6 months.
This date and time was extracted directly from ELTP's own Form 8-K (earnings press release) filed with the U.S. Securities and Exchange Commission — not an analyst estimate or a third-party calendar. We mark a report “confirmed” only when the company itself has stated the date in a public SEC filing, and we link that filing above so you can verify it. Everything else stays an honest estimate from the company's filing cadence. From filings, not guesses.
Projected from ELTP's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentELTP files or announces.
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.